Literature DB >> 31023820

Reply to Frange and Leruez-Ville, "Caution Is Required before Recommending Wide Use of Letermovir as Salvage Therapy for Cytomegalovirus Diseases".

Nicholas A Turner1, Cameron R Wolfe1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31023820      PMCID： PMC6496054          DOI： 10.1128/AAC.00453-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  5 in total

1.  Cytomegalovirus retinitis successfully treated with ganciclovir implant in a patient with blood ganciclovir resistance and ocular ganciclovir sensitivity.

Authors:  N K Bakshi; G A Fahle; I Sereti; H Wiley; R B Nussenblatt; H N Sen
Journal:  Eye (Lond)       Date:  2012-02-10       Impact factor: 3.775

2.  Comparison of intravitreal ganciclovir monotherapy and combination with foscarnet as initial therapy for cytomegalovirus retinitis.

Authors:  Jing-Jing Fan; Yong Tao; De-Kuang Hwang
Journal:  Int J Ophthalmol       Date:  2018-10-18       Impact factor: 1.779

3.  Use of Letermovir as Salvage Therapy for Drug-Resistant Cytomegalovirus Retinitis.

Authors:  Nicholas Turner; Andrew Strand; Dilraj S Grewal; Gary Cox; Sana Arif; Arthur W Baker; Eileen K Maziarz; Jennifer H Saullo; Cameron R Wolfe
Journal:  Antimicrob Agents Chemother       Date:  2019-02-26       Impact factor: 5.191

4.  Rapid In Vitro Evolution of Human Cytomegalovirus UL56 Mutations That Confer Letermovir Resistance.

Authors:  Sunwen Chou
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

5.  Genotypic analysis of cytomegalovirus retinitis poorly responsive to intravenous ganciclovir but responsive to the ganciclovir implant.

Authors:  Irene C Kuo; Yumi Imai; Carol Shum; Daniel F Martin; Baruch D Kuppermann; Todd P Margolis
Journal:  Am J Ophthalmol       Date:  2003-01       Impact factor: 5.258
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.